• Login
Redica Systems
  • For Pharma

    Our data generates critical pharma insights with our actionable data intelligence helping your team go from reactive to proactive.

    For MedTech

    Elevate your MedTech quality and regulatory strategies with our comprehensive intelligence solutions and unparalleled dataset.

  • Catalyst
  • About Us
    • People
    • Careers
    • Press
  • Resources

    View all Resources

    • Assessments
    • Reports
    • Webinars
    • Glossary
  • Blog
Request a Demo
Redica Systems
    • Redica Systems MedTech Intelligence
    • Redica Systems Pharma Intelligence
  • Catalyst
    • About Redica Systems
    • People
    • Careers
    • Press
  • Resources
  • Blog
Request a Demo
  • Login

Resources

FDA Consent Decrees: How do you make compliance sustainable?

By the time a consent decree comes along, it’s no longer a discussion about responses to Form FDA 483s observations replete with well-turned phrases—it’s about a DIY Network renovation—a complete makeover. It’s a “gut-it” approach, as never before, which exposes the cracked foundation and termite-eaten beams weakened over time. This is because the common element […]

FDA Consent Decrees: the Cost of Doing Business?

The strategic reasons behind the acquisition in the works for Sanofi to purchase Genzyme are clear. It was a matter of fixing a sale price that reflected the true current and future value of Genzyme. For those of us in the quality assurance and regulatory compliance professions, there has been the curiosity of how the […]

Report Documents Dramatic Increases In Form FDA 483 Citations For Pharma and Biotech Firms

(Chicago) March 7, 2010 — Though it can cost hundreds of thousands of dollars to respond to a single Form FDA 483, many pharma manufacturers aren’t taking some of the basic steps needed to avoid being cited, according to new research published by FDAzilla, one of the Web’s leading sources on the business of the […]

10 Reasons Why the Deviation Investigation System Fails

For some companies, manufacturing is a crapshoot. There is little basis for confidence that the right equipment, materials, components, people, and records will be at the right place and the right time to begin manufacturing. And once manufacturing starts, a crystal ball is as good as anything to divine whether the product batch will be […]

FDA Continues to Look at Re-classifying Numerous Medical Devices

The FDA has spent much of January focused on American medical device issues. In particular, they have been reviewing the regulatory status of several classes of medical devices already on the market. The latest segment of the industry to be subjected to FDA scrutiny is the manufacturing of external defibrillators. External defibrillators have gained a […]

What iPad Apps are really medical devices?

The ease of application development afforded by the extensive community surrounding portable devices like the Apple iPhone/iPad has led to a surge in medical device-like apps being released for smart phones and tablets. An article published by Siren Interactive quoted a MobiHealthNews study that found more than 7,000 medical apps available for the iPhone in […]

Unintended Consequences of Authority

I remember when I was a freshly minted executive taking a window tour of the manufacturing facility. While listening to a staff member talk about the operation, I idly traced my fingertip on an ever-so-slight mar on the finish of the corridor wall, as I was lost in thought. Little did I know the chain […]

Company Culture and CGMP Compliance

I’ve come to the conclusion that compliance with the FDA Current Good Manufacturing Practices (CGMP) is just as much about company culture as it is about anything else. A corollary to this is that resolution of regulatory compliance problems is just as much about organization transformation than anything else. I have divided companies with significant […]

Top 31 Websites (and Tweeters) on the FDA

If any part of your life includes trying to figure out how to work smarter with the FDA, this is for you.  Here’s our list of the top 40 31 online destinations on the FDA and some of the key industries it regulates.   We applied only one criteria to make it on this list:  free, up-to-date, […]

Who Owns the Quality System: Everybody, Somebody or Nobody?

Of course, I understand that everyone in the organization owns “quality.” Much like safety, everyone has responsibility to follow safe practices and call attention to potentially unsafe conditions. However, there also is a Safety Department that is responsible for establishing safety policies and procedures, as well as conducting periodic safety inspections. They report the safety […]
« Older Entries
Newer Entries »
Company
  • About Redica Systems
  • People
  • Careers
  • Press
  • Contact Us
Catalyst
  • Redica Catalyst
  • Redica ID
  • Enrichment
  • Knowledge Graph
  • Redica Ontologies
Use Cases
  • For Pharma
  • For MedTech
  • Inspection Preparation
  • Vendor Quality
  • Regulatory Surveillance
Resources
  • Assessments
  • Reports
  • Webinars
  • Document Store
  • Blog
  • Glossary

© 2025 Redica. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
  • Status